GRHL3 | grainyhead-like transcription factor 3 | 1p36 | 0.443 | 0.611 | 0
|
ZNF823 | zinc finger protein 823 | 19p13.2 | 0.439 | 0.64 | 0
|
ZNF107 | zinc finger protein 107 | 7q11.2 | 0.434 | 0.589 | 0
|
ZNF681 | zinc finger protein 681 | 19p12 | 0.425 | 0.63 | 0
|
RBBP8NL | RBBP8 N-terminal like | 20q13.33 | 0.422 | 0.634 | 0
|
RHOU | ras homolog family member U | 1q42.11-q42.3 | 0.421 | 0.59 | 0
|
MYCL | v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog | 1p34.3 | 0.418 | 0.659 | 0
|
ACOX1 | acyl-CoA oxidase 1, palmitoyl | 17q25.1 | 0.41 | 0.631 | 0
|
ITSN2 | intersectin 2 | 2p23.3 | 0.408 | 0.587 | 0
|
TMEM97 | transmembrane protein 97 | 17q11.2 | 0.408 | 0.639 | 0
|
EPB41 | erythrocyte membrane protein band 4.1 | 1p33-p32 | 0.406 | 0.606 | 0
|
RAB11FIP4 | RAB11 family interacting protein 4 (class II) | 17q11.2 | 0.406 | 0.622 | 0
|
POGK | pogo transposable element with KRAB domain | 1q23.2 | 0.406 | 0.584 | 0
|
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | 1p21.3 | 0.4 | 0.597 | 0
|
SLC9A2 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | 2q11.2 | 0.398 | 0.643 | 0
|
SLC30A2 | solute carrier family 30 (zinc transporter), member 2 | 1p35.3 | 0.398 | 0.604 | 0
|
SLC9A4 | solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 | 2q12.1 | 0.397 | 0.625 | 0
|
ALDH5A1 | aldehyde dehydrogenase 5 family, member A1 | 6p22 | 0.396 | 0.557 | 0
|
IFITM3 | interferon induced transmembrane protein 3 | 11p15.5 | 0.395 | -0.586 | 0
|
MSN | moesin | Xq11.1 | 0.394 | -0.554 | 0
|
SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 6p25.2 | 0.393 | -0.567 | 0
|
ZNF217 | zinc finger protein 217 | 20q13.2 | 0.391 | 0.516 | 0
|
ZNF675 | zinc finger protein 675 | 19p12 | 0.388 | 0.598 | 0
|
DPYD | dihydropyrimidine dehydrogenase | 1p22 | 0.388 | -0.599 | 0
|
PAXIP1-AS1 | PAXIP1 antisense RNA 1 (head to head) | 7q36.2 | 0.386 | 0.522 | 0
|
SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 5p15.2 | 0.382 | 0.584 | 0
|
ZBTB8B | zinc finger and BTB domain containing 8B | 1p35.1 | 0.376 | 0.602 | 0
|
IFI27L2 | interferon, alpha-inducible protein 27-like 2 | 14q32.13 | 0.376 | -0.557 | 0
|
IL15 | interleukin 15 | 4q31 | 0.375 | -0.558 | 0
|
LAMA3 | laminin, alpha 3 | 18q11.2 | 0.375 | -0.556 | 0
|
SAMD10 | sterile alpha motif domain containing 10 | 20q13.33 | 0.373 | 0.478 | 0
|
IFI16 | interferon, gamma-inducible protein 16 | 1q22 | 0.368 | -0.569 | 0
|
PARD6B | par-6 family cell polarity regulator beta | 20q13.13 | 0.366 | 0.519 | 0
|
CD68 | CD68 molecule | 17p13 | 0.363 | -0.529 | 0
|
TTC39A | tetratricopeptide repeat domain 39A | 1p32.3 | 0.36 | 0.555 | 0
|
FAS | Fas cell surface death receptor | 10q24.1 | 0.359 | -0.543 | 0
|
ZNF3 | zinc finger protein 3 | 7q22.1 | 0.358 | 0.512 | 0
|
ZNF398 | zinc finger protein 398 | 7q35 | 0.357 | 0.586 | 0
|
GCNT4 | glucosaminyl (N-acetyl) transferase 4, core 2 | 5q12 | 0.357 | 0.531 | 0
|
PDXDC1 | pyridoxal-dependent decarboxylase domain containing 1 | 16p13.11 | 0.356 | 0.504 | 0
|
SVOPL | SVOP-like | 7q34 | 0.354 | 0.584 | 0
|
DOCK3 | dedicator of cytokinesis 3 | 3p21 | 0.353 | 0.545 | 0
|
NDUFB2-AS1 | NDUFB2 antisense RNA 1 | 7q34 | 0.352 | 0.548 | 0
|
TRIM45 | tripartite motif containing 45 | 1p13.1 | 0.352 | 0.525 | 0
|
TMEM254 | transmembrane protein 254 | 10q23.1 | 0.351 | 0.526 | 0
|
SASH1 | SAM and SH3 domain containing 1 | 6q24.3 | 0.35 | 0.427 | 0
|
VGLL1 | vestigial-like family member 1 | Xq26.3 | 0.35 | 0.601 | 0
|
GDPD3 | glycerophosphodiester phosphodiesterase domain containing 3 | 16p11.2 | 0.348 | 0.57 | 0
|
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 16q22.1 | 0.346 | -0.376 | 7.77e-16
|
ZNF761 | zinc finger protein 761 | 19q13.42 | 0.344 | 0.607 | 0
|
NCOA1 | nuclear receptor coactivator 1 | 2p23 | 0.342 | 0.387 | 0
|
TLR2 | toll-like receptor 2 | 4q32 | 0.34 | -0.5 | 0
|
NLK | nemo-like kinase | 17q11.2 | 0.338 | 0.56 | 0
|
GUCA2A | guanylate cyclase activator 2A (guanylin) | 1p35-p34 | 0.338 | 0.548 | 0
|
PI4KAP1 | phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 1 | 22q11.21 | 0.338 | 0.553 | 0
|
LAMB3 | laminin, beta 3 | 1q32 | 0.337 | -0.464 | 0
|
LRRC8C | leucine rich repeat containing 8 family, member C | 1p22.2 | 0.336 | -0.508 | 0
|
LOC284379 | | | 0.336 | 0.51 | 0
|
LYPD6 | LY6/PLAUR domain containing 6 | 2q23.2 | 0.336 | 0.522 | 0
|
GTF2IP1 | general transcription factor IIi pseudogene 1 | 7q11.23 | 0.335 | 0.54 | 0
|
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 6p22.1 | 0.335 | 0.484 | 0
|
DHRS11 | dehydrogenase/reductase (SDR family) member 11 | 17q12 | 0.331 | 0.465 | 0
|
PMEL | premelanosome protein | 12q13-q14 | 0.325 | 0.503 | 0
|
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 20q11.2 | 0.322 | 0.553 | 0
|
ESRP1 | epithelial splicing regulatory protein 1 | 8q22.1 | 0.318 | 0.469 | 0
|
SERPINB3 | serpin peptidase inhibitor, clade B (ovalbumin), member 3 | 18q21.3 | 0.317 | -0.394 | 0
|
C19orf35 | chromosome 19 open reading frame 35 | 19p13.3 | 0.317 | -0.379 | 3.34e-16
|
MAN2A2 | mannosidase, alpha, class 2A, member 2 | 15q25 | 0.317 | 0.425 | 0
|
KHDC1 | KH homology domain containing 1 | 6q13 | 0.316 | -0.483 | 0
|
DFNA5 | deafness, autosomal dominant 5 | 7p15 | 0.316 | -0.512 | 0
|
ATP6V0E2 | ATPase, H+ transporting V0 subunit e2 | 7q36.1 | 0.315 | 0.484 | 0
|
TMEM64 | transmembrane protein 64 | 8q21.3 | 0.313 | 0.337 | 1.24e-12
|
STX3 | syntaxin 3 | 11q12.1 | 0.312 | 0.44 | 0
|
DDX24 | DEAD (Asp-Glu-Ala-Asp) box helicase 24 | 14q32 | 0.311 | -0.514 | 0
|
MT1E | metallothionein 1E | 16q13 | 0.311 | -0.474 | 0
|
TMEM254-AS1 | TMEM254 antisense RNA 1 | 10q22.3 | 0.308 | 0.479 | 0
|
C1orf198 | chromosome 1 open reading frame 198 | 1q42.2 | 0.308 | 0.407 | 0
|
CDIP1 | cell death-inducing p53 target 1 | 16p13.3 | 0.308 | -0.458 | 0
|
CD24 | CD24 molecule | 6q21 | 0.307 | 0.481 | 0
|
FN3K | fructosamine 3 kinase | 17q25 | 0.307 | 0.406 | 0
|
CYB561 | cytochrome b561 | 17q23.3 | 0.306 | 0.364 | 1.06e-14
|
AP1B1 | adaptor-related protein complex 1, beta 1 subunit | 22q12.2 | 0.304 | 0.447 | 0
|
CREB3L2 | cAMP responsive element binding protein 3-like 2 | 7q34 | 0.301 | 0.508 | 0
|
GLCCI1 | glucocorticoid induced 1 | 7p22.2 | 0.299 | 0.49 | 0
|
SNAPC1 | small nuclear RNA activating complex, polypeptide 1, 43kDa | 14q22 | 0.298 | -0.428 | 0
|
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | 2q36.1 | 0.296 | -0.425 | 0
|
GGCX | gamma-glutamyl carboxylase | 2p12 | 0.296 | 0.431 | 0
|
MVP | major vault protein | 16p11.2 | 0.295 | -0.454 | 0
|
PPAPDC1B | phospholipid phosphatase 5 | 8p12 | 0.286 | 0.494 | 0
|
BHLHB9 | basic helix-loop-helix domain containing, class B, 9 | Xq23 | 0.284 | 0.395 | 0
|
RAPGEF5 | Rap guanine nucleotide exchange factor (GEF) 5 | 7p15.3 | 0.281 | -0.286 | 2.07e-09
|
PIGU | phosphatidylinositol glycan anchor biosynthesis, class U | 20q11.22 | 0.281 | 0.41 | 0
|
AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | 6q25.3 | 0.278 | -0.427 | 0
|
TLL1 | tolloid-like 1 | 4q32-q33 | 0.277 | -0.389 | 0
|
IGSF9 | immunoglobulin superfamily, member 9 | 1q22-q23 | 0.276 | 0.437 | 0
|
TOR4A | torsin family 4, member A | 9q34.3 | 0.275 | -0.457 | 0
|
HCG4 | HLA complex group 4 (non-protein coding) | 6p22.1 | 0.273 | -0.399 | 0
|
RGS9BP | regulator of G protein signaling 9 binding protein | 19q13.11 | 0.27 | 0.374 | 1.1e-15
|
PIWIL3 | piwi-like RNA-mediated gene silencing 3 | 22q11.23 | 0.266 | 0.417 | 0
|
RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 1p | 0.263 | -0.387 | 0
|
CCR7 | chemokine (C-C motif) receptor 7 | 17q12-q21.2 | 0.261 | 0.365 | 7.83e-15
|
C17orf58 | chromosome 17 open reading frame 58 | 17q24.2 | 0.26 | 0.378 | 4.8e-16
|
GOLGA2 | golgin A2 | 9q34.13 | 0.26 | 0.317 | 2.8e-11
|
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D | 14q23-q24.2 | 0.256 | -0.372 | 2.11e-15
|
SEC22B | SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) | 1q21.1 | 0.255 | 0.326 | 6.47e-12
|
CASC10 | cancer susceptibility candidate 10 | 10p12.31 | 0.253 | 0.367 | 5.59e-15
|
KLF8 | Kruppel-like factor 8 | Xp11.21 | 0.252 | 0.371 | 2.21e-15
|
MOSPD1 | motile sperm domain containing 1 | Xq26.3 | 0.25 | 0.41 | 0
|
PGRMC2 | progesterone receptor membrane component 2 | 4q26 | 0.25 | 0.453 | 0
|
ADCK2 | aarF domain containing kinase 2 | 7q34 | 0.245 | 0.413 | 0
|
SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 19p13.12 | 0.242 | 0.456 | 0
|
TMEM139 | transmembrane protein 139 | 7q34 | 0.241 | 0.348 | 1.79e-13
|
POMGNT2 | protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | 3p22.1 | 0.24 | 0.332 | 2.4e-12
|
UXS1 | UDP-glucuronate decarboxylase 1 | 2q12.2 | 0.239 | 0.364 | 9.84e-15
|
SMARCD2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 | 17q23.3 | 0.237 | 0.325 | 7.25e-12
|
HOXD8 | homeobox D8 | 2q31.1 | 0.234 | -0.334 | 1.8e-12
|
PCSK6 | proprotein convertase subtilisin/kexin type 6 | 15q26 | 0.232 | 0.319 | 2.03e-11
|
SQLE | squalene epoxidase | 8q24.1 | 0.229 | 0.348 | 1.89e-13
|
PER2 | period circadian clock 2 | 2q37.3 | 0.228 | -0.288 | 1.51e-09
|
TMEM214 | transmembrane protein 214 | 2p23.3 | 0.224 | 0.362 | 1.46e-14
|
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 6q26 | 0.221 | -0.334 | 1.78e-12
|
HOXB9 | homeobox B9 | 17q21.32 | 0.218 | -0.288 | 1.67e-09
|
HIST3H2A | histone cluster 3, H2a | 1q42.13 | 0.217 | 0.345 | 2.82e-13
|
COPG1 | coatomer protein complex, subunit gamma 1 | 3q21.3 | 0.216 | 0.393 | 0
|
GOLGA7B | golgin A7 family, member B | 10q24.2 | 0.216 | -0.235 | 1e-06
|
HIST1H2BH | histone cluster 1, H2bh | 6p22.2 | 0.21 | 0.171 | 0.000409
|